Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Int J Biol Macromol ; 192: 90-99, 2021 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-34619276

RESUMO

During HIV-1 infection, the envelope glycoprotein subunit gp41 folds into a six-helix bundle structure (6HB) formed by the interaction between its N-terminal (NHR) and C-terminal (CHR) heptad-repeats, promoting viral and cell membranes fusion. A highly preserved, hydrophobic pocket (HP) on the NHR surface is crucial in 6HB formation and, therefore, HP-binding compounds constitute promising therapeutics against HIV-1. Here, we investigated the conformational and dynamic properties of the HP using a rationally designed single-chain protein (named covNHR) that mimics the gp41 NHR structure. We found that the fluorescent dye 8-anilino-naphtalene-1-sulfonic acid (ANS) binds specifically to the HP, suggesting that ANS derivatives may constitute lead compounds to inhibit 6HB formation. ANS shows different binding modes to the HP, depending on the occupancy of other NHR pockets. Moreover, in presence of a CHR peptide bound to the N-terminal pockets in gp41, two ANS molecules can occupy the HP showing cooperative behavior. This binding mode was assessed using molecular docking and molecular dynamics simulations. The results show that the HP is conformationally flexible and connected allosterically to other NHR regions, which strongly influence the binding of potential ligands. These findings could guide the development of small-molecule HIV-1 inhibitors targeting the HP.


Assuntos
Sequência de Aminoácidos , Domínio Catalítico , Sequência Conservada , Proteína gp41 do Envelope de HIV/química , Interações Hidrofóbicas e Hidrofílicas , Modelos Moleculares , Conformação Proteica , Sítios de Ligação , Desenho de Fármacos , Proteína gp41 do Envelope de HIV/antagonistas & inibidores , Inibidores da Fusão de HIV/química , Inibidores da Fusão de HIV/farmacologia , Humanos , Simulação de Acoplamento Molecular , Simulação de Dinâmica Molecular , Fragmentos de Peptídeos/química , Ligação Proteica , Análise Espectral , Termodinâmica
2.
Int J Mol Sci ; 22(12)2021 Jun 14.
Artigo em Inglês | MEDLINE | ID: mdl-34198692

RESUMO

The formation of fibrillar aggregates of the amyloid beta peptide (Aß) in the brain is one of the hallmarks of Alzheimer's disease (AD). A clear understanding of the different aggregation steps leading to fibrils formation is a keystone in therapeutics discovery. In a recent study, we showed that Aß40 and Aß42 form dynamic micellar aggregates above certain critical concentrations, which mediate a fast formation of more stable oligomers, which in the case of Aß40 are able to evolve towards amyloid fibrils. Here, using different biophysical techniques we investigated the role of different fractions of the Aß aggregation mixture in the nucleation and fibrillation steps. We show that both processes occur through bimolecular interplay between low molecular weight species (monomer and/or dimer) and larger oligomers. Moreover, we report here a novel self-catalytic mechanism of fibrillation of Aß40, in which early oligomers generate and deliver low molecular weight amyloid nuclei, which then catalyze the rapid conversion of the oligomers to mature amyloid fibrils. This fibrillation catalytic activity is not present in freshly disaggregated low-molecular weight Aß40 and is, therefore, a property acquired during the aggregation process. In contrast to Aß40, we did not observe the same self-catalytic fibrillation in Aß42 spheroidal oligomers, which could neither be induced to fibrillate by the Aß40 nuclei. Our results reveal clearly that amyloid fibrillation is a multi-component process, in which dynamic collisions between different interacting species favor the kinetics of amyloid nucleation and growth.


Assuntos
Peptídeos beta-Amiloides/química , Benzotiazóis/química , Fenômenos Biofísicos , Catálise , Linhagem Celular Tumoral , Sobrevivência Celular , Humanos , Cinética , Peso Molecular , Conformação Proteica
3.
J Mol Biol ; 432(20): 5577-5592, 2020 09 18.
Artigo em Inglês | MEDLINE | ID: mdl-32822695

RESUMO

One of the therapeutic strategies in HIV neutralization is blocking membrane fusion. In this process, tight interaction between the N-terminal and C-terminal heptad-repeat (NHR and CHR) regions of gp41 is essential to promote membranes apposition and merging. We have previously developed single-chain proteins (named covNHR) that accurately mimic the complete gp41 NHR region in its trimeric conformation. They tightly bind CHR-derived peptides and show a potent and broad HIV inhibitory activity in vitro. However, the extremely high binding affinity (sub-picomolar) is not in consonance with their inhibitory activity (nanomolar), likely due to partial or temporal accessibility of their target in the virus. Here, we have designed and characterized two single-chain covNHR miniproteins each encompassing one of the two halves of the NHR region and containing two of the four sub-pockets of the NHR crevice. The two miniproteins fold as trimeric helical bundles as expected but while the C-terminal covNHR (covNHR-C) miniprotein is highly stable, the N-terminal counterpart (covNHR-N) shows only marginal stability that could be improved by engineering an internal disulfide bond. Both miniproteins bind their respective complementary CHR peptides with moderate (micromolar) affinity. Moreover, the covNHR-N miniproteins can access their target in the context of trimeric native envelope proteins and show significant inhibitory activity for several HIV pseudoviruses. In contrast, covNHR-C cannot bind its target sequence and neither inhibits HIV, indicating a higher vulnerability of C-terminal part of CHR. These results may guide the development of novel HIV inhibitors targeting the gp41 CHR region.


Assuntos
Fármacos Anti-HIV/farmacologia , Proteína gp41 do Envelope de HIV/química , Proteína gp41 do Envelope de HIV/efeitos dos fármacos , HIV-1/efeitos dos fármacos , HIV-1/metabolismo , Sequência de Aminoácidos , Fusão de Membrana/efeitos dos fármacos , Modelos Moleculares , Peptídeos , Conformação Proteica , Engenharia de Proteínas , Multimerização Proteica , Proteínas do Envelope Viral/química
4.
Arch Biochem Biophys ; 688: 108401, 2020 07 30.
Artigo em Inglês | MEDLINE | ID: mdl-32376316

RESUMO

HIV-1 glycoprotein 41 (gp41) mediates fusion between virus and target cells by folding into a fusion active state, in which the C-terminal heptad repeat (CHR) regions associate externally to the N-terminal heptad repeat (NHR) trimer and form a very stable six-helix bundle coiled-coil structure. Therefore, interfering with the NHR-CHR interaction of gp41 is a promising therapeutic approach against HIV-1. However, a full understanding of the molecular and mechanistic details of this interaction is still incomplete. Here, we use single-chain, chimeric proteins (named covNHR) that reproduce accurately the CHR-NHR interactions to analyze the binding thermodynamics of several peptides with different length from the CHR region. The results indicate that cooperative binding involving two or more pockets of the NHR groove is necessary to obtain relevant affinities and that the binding energy is broadly distributed along the interface, underlining a crucial role of a middle pocket to achieve tight binding. In contrast, targeting only the deep hydrophobic pocket is insufficient to achieve significant affinity. Moreover, calorimetry experiments in combination with limited proteolysis performed using a mutant with occluded binding in the N-terminal pocket reveal the existence of an allosteric communication between the different regions. This study is the first detailed thermodynamic dissection of the NHR-CHR interaction in gp41 and contributes therefore to a better understanding of HIV fusion. These results are relevant for the development of potential fusion inhibitors.


Assuntos
Proteína gp41 do Envelope de HIV/metabolismo , HIV-1/química , Fragmentos de Peptídeos/metabolismo , Motivos de Aminoácidos , Sequência de Aminoácidos , Calorimetria , Proteína gp41 do Envelope de HIV/química , Fragmentos de Peptídeos/química , Ligação Proteica , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/metabolismo , Termodinâmica
5.
J Mol Biol ; 431(17): 3091-3106, 2019 08 09.
Artigo em Inglês | MEDLINE | ID: mdl-31255705

RESUMO

Development of effective inhibitors of the fusion between HIV-1 and the host cell membrane mediated by gp41 continues to be a grand challenge due to an incomplete understanding of the molecular and mechanistic details of the fusion process. We previously developed single-chain, chimeric proteins (named covNHR) that accurately mimic the N-heptad repeat (NHR) region of gp41 in a highly stable coiled-coil conformation. These molecules bind strongly to peptides derived from the gp41 C-heptad repeat (CHR) and are potent and broad HIV-1 inhibitors. Here, we investigated two covNHR variants differing in two mutations, V10E and Q123R (equivalent to V38E and Q40R in gp41 sequence) that reproduce the effect of HIV-1 mutations associated with resistance to fusion inhibitors, such as T20 (enfuvirtide). A detailed calorimetric analysis of the binding between the covNHR proteins and CHR peptides (C34 and T20) reveals drastic changes in affinity due to the mutations as a result of local changes in interactions at the site of T20 resistance. The crystallographic structure of the covNHR:C34 complex shows a virtually identical CHR-NHR binding interface to that of the post-fusion structure of gp41 and underlines an important role of buried interfacial water molecules in binding affinity and in development of resistance against CHR peptides. Despite the great difference in affinity, both covNHR variants demonstrate strong inhibitory activity for a wide variety of HIV-1 strains. These properties support the high potential of these covNHR proteins as new potent HIV-1 inhibitors. Our results may guide future inhibition approaches.


Assuntos
Proteína gp41 do Envelope de HIV/química , Proteína gp41 do Envelope de HIV/metabolismo , HIV-1/metabolismo , Termodinâmica , Internalização do Vírus/efeitos dos fármacos , Sequência de Aminoácidos , Fármacos Anti-HIV/farmacologia , Cristalografia por Raios X , Enfuvirtida/antagonistas & inibidores , Proteína gp41 do Envelope de HIV/genética , HIV-1/efeitos dos fármacos , HIV-1/genética , Modelos Moleculares , Mutação , Peptídeos , Conformação Proteica , Análise de Sequência de Proteína
6.
Phys Chem Chem Phys ; 20(31): 20597-20614, 2018 Aug 08.
Artigo em Inglês | MEDLINE | ID: mdl-30059119

RESUMO

A deep understanding of the early molecular mechanism of amyloid beta peptides (Aß) is crucial to develop therapeutic and preventive approaches for Alzheimer's disease (AD). Using a variety of biophysical techniques, we have found that micelle-like dynamic oligomers are rapidly formed by Aß40 and Aß42 above specific critical concentrations. Analysis of the initial aggregation rates at 37 °C measured by thioflavin T and Bis-ANS fluorescence using a mass-action micellization model revealed a concentration-dependent switch in the nucleation mechanism. Bimolecular nucleation appears to occur at low peptide concentration while above the critical micellar concentration, the nucleation takes place more efficiently in the micelles. Upon incubation, these micelles mediate a rapid formation of larger, more stable oligomers enriched in beta-sheet structure. These oligomers formed from Aß40, enriched in amyloid nuclei, acquire a higher capacity to fibrillate than their micellar precursors. Aß42 can also form similar oligomers but they have lower beta-sheet structure content and lower capacity to fibrillate. On the other hand, a considerable fraction of the Aß42 peptide forms morphologically distinct oligomers that are unable to fibrillate and show significant effect on SH-SY5Y cell viability. Overall, our results highlight the importance of micellar structures as mediators of amyloid nucleation and contribute to the understanding of the differences between the aggregation pathways of Aß40 and Aß42.


Assuntos
Peptídeos beta-Amiloides/metabolismo , Micelas , Fragmentos de Peptídeos/metabolismo , Doença de Alzheimer/metabolismo , Doença de Alzheimer/patologia , Peptídeos beta-Amiloides/química , Peptídeos beta-Amiloides/toxicidade , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Cromatografia em Gel , Difusão Dinâmica da Luz , Humanos , Microscopia de Força Atômica , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/toxicidade , Agregados Proteicos/fisiologia , Espectroscopia de Infravermelho com Transformada de Fourier
7.
Artigo em Inglês | MEDLINE | ID: mdl-19033475

RESUMO

Since 1996, AID FOR AIDS International (AFAI) has collected unused antiretroviral drugs (ART) and ;;recycled'' these medications to over 600 people living with human immunodeficiency virus/AIDS abroad under its AIDS Treatment Access Program. The investigators evaluated AIDS Treatment Access Program's efficacy using immunologic and virologic outcomes. Of the 404 eligible clients who had baseline and follow-up CD4 counts, mean baseline versus most recent measure was 230 + 222 cells/mm( 3) versus 372 + 256 cells/mm(3) (P < .01). Of the 216 eligible clients who had baseline (>400 copies/mL) and follow-up viral loads, 62% (134/ 216) had undetectable viral loads (<400 copies/mL) at their most recent measure. Median enrollment time in the recycling program was 3.1 years (range: 6 months to 9.5 years). AFAI's medication recycling program is efficacious in reaching and improving the clinical outcomes of people living with HIV/AIDS (PLWHA). Such programs should be considered a viable option among scale-up programs until governments provide universal access of ART to PLWHA.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Infecções por HIV/tratamento farmacológico , Acessibilidade aos Serviços de Saúde , Relações Interinstitucionais , Cooperação Internacional , Adolescente , Adulto , Idoso , Antirretrovirais/uso terapêutico , Contagem de Linfócito CD4 , Criança , Pré-Escolar , Países em Desenvolvimento , Indústria Farmacêutica/economia , Quimioterapia Combinada , Feminino , Infecções por HIV/sangue , Humanos , Lactente , Agências Internacionais , Masculino , Pessoa de Meia-Idade , Pobreza , Resultado do Tratamento , Nações Unidas , Estados Unidos , Carga Viral , Adulto Jovem
8.
Salud ment ; 21(3): 26-31, mayo-jun. 1998. tab
Artigo em Espanhol | LILACS | ID: lil-243154

RESUMO

El presente trabajo reporta el proceso psicométrico realizado en la Ciudad de México para estandarizar el Inventario de Depresión de Beck (Beck Depression Inventory, BD). Se realizaron tres estudios. El primero siguió los lineamientos internacionalmente establecidos para traducir y adaptar instrumentos de evaluación psicológica. La muestra normativa fue de 1508 personas adultas de entre 15 y 65 años de edad. La confiabilidad por consistencia interna obtenida fue: alfa de Cronbach = 0.87, p < .000. El análisis factorial mostró que la versión mexicana, al igual que la original, se compone por tres factores. Por último se obtuvieron las tablas normativas tanto para estudiantes como por la población general. El segundo, evaluó la validez concurrente entre el BDI y la Escala de Zung en una muestra de 120 personas con diagnóstico psiquiátrico de depresión y con edades de entre 17 y 72 años. La correlación estadística entre ambas escalas fue: r = 0.70, p < .000. El tercer estudio, evaluó nuevamente la validez consurrente entre el BDI y la Escala de Zung, pero esta vez en una población de 546 estudiantes de bachillerato, con edades entre 15 y 23 años. La correlación estadística entre ambas escalas fue: r = 0.65, p < .000. Se concluye que el BDI desarrollado en este estudio cumple con los requisitos psicométricos de confiabilidad y validez requeridos psicométricamente para evaluar los niveles de depresión en residentes de la ciudad de México. Finalmente, se resalta la importancia de dar cumplimiento cabal al proceso psicométrico y a los lineamientos internacionalmente aceptados para la traducción y adaptación de instrumentos de medición psicológica


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Psicometria , Psicometria/instrumentação , Reprodutibilidade dos Testes , Transtorno Depressivo/diagnóstico , Transtorno Depressivo/psicologia , Escalas de Graduação Psiquiátrica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA